Hypophosphatemia After Intravenous Ferric Carboxymaltose in Heart Transplant Patients

被引：0
|
作者：
Santulario-Verdu, L. [1 ]
Echeverry-Navarrete, E. [2 ]
Diez-Lopez, C. [2 ]
Canedo-Castelo, M. [1 ]
Juvany-Roig, R. [1 ]
Garcia-Romero, E. [2 ]
Roca-Elias, J. [2 ]
Manito-Lorite, N. [2 ]
Gonzalez-Costello, J. [2 ]
机构：
[1] Bellvitge Univ Hosp, Pharm, Barcelona, Spain
[2] Bellvitge Univ Hosp, Cardiol, Barcelona, Spain
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2022年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
512
引用
收藏
页码：S220 / S221
页数：2
相关论文
共 50 条
  • [21] Intravenous Ferric Carboxymaltose-Induced Hypophosphatemia in a Patient with Systemic Lupus Erythematosus: Case Report
    Al Qassimi, Sarah
    Namas, Rajaie
    El-Kaissi, Samer
    IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2024, 16 (03): : 123 - 125
  • [22] Intravenous ferric carboxymaltose treatment in cancer patients.
    Aslan, Alma
    Tasdemir, Vildan
    Kertmen, Neyran
    Dizdar, Omer
    Aksoy, Sercan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] HYPOPHOSPHATEMIA INDUCED BY INTRAVENOUS ADMINISTRATION OF FERRIC CARBOXYMALTOSE IN NONDIALYSIS CHRONIC KIDNEY DISEASE PATIENTS IS NOT MEDIATED BY FGF23
    Prats, Merche
    Font, Ramon
    Garcia, Carmen
    Cabre, Carmen
    Jariod, Manel
    Martinez Vea, Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 10 - 10
  • [24] Ferric carboxymaltose-induced hypophosphatemia - a case series
    Ferreira, C. Campinho
    Pereira, P.
    Correira, M.
    Costa, E.
    Almeida, D. Esperanca
    Costa, J. Redondo
    Ribeiro, A. Roxo
    Silva, J. Leite
    ARP RHEUMATOLOGY, 2024, 3 (03): : 226 - 230
  • [25] High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia
    Stoehr, Robert
    Sandstede, Lukas
    Heine, Gunnar H.
    Marx, Nikolaus
    Brandenburg, Vincent
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (19) : 2270 - 2271
  • [26] Severe hyperthermia after Intravenous Ferric Carboxymaltose (Injectafer®) administration
    Motosan, Claudia
    El Amine, Myriam
    Mols, Pierre
    Ramadan, Ahmed S. E.
    ACTA CLINICA BELGICA, 2014, 69 : S8 - S8
  • [27] Intravenous ferric carboxymaltose for anaemia in pregnancy
    Froessler, Bernd
    Collingwood, Joshua
    Hodyl, Nicolette A.
    Dekker, Gustaaf
    BMC PREGNANCY AND CHILDBIRTH, 2014, 14
  • [28] Trends of phosphorus levels after intravenous administration of ferric carboxymaltose
    Borrellas, A.
    Domingo, M.
    Lupon, J.
    Pulido, A.
    Gonzalez, B.
    Rivas, C.
    Velayos, P.
    Bares, D.
    Diaz, V.
    Crespo, E.
    Martinez, S.
    Codina, P.
    Santiago-Vacas, E.
    Cediel, G.
    Bayes-Genis, A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [29] Intravenous ferric carboxymaltose for anaemia in pregnancy
    Bernd Froessler
    Joshua Collingwood
    Nicolette A Hodyl
    Gustaaf Dekker
    BMC Pregnancy and Childbirth, 14
  • [30] Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France
    Bourguignon, Sandrine
    Faller, Mathilde
    Champs, Francois-Olivier
    Moutier, Helene
    Levesque, Karine
    Caranhac, Gilbert
    Cohen-Solal, Alain
    ESC HEART FAILURE, 2019, 6 (03): : 559 - 569
12345